Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.8%
5Y CAGR+61.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+34.8%/yr
vs +41.2%/yr prior
5Y CAGR
+61.0%/yr
Recent deceleration
Acceleration
-6.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $66.27M | +27.5% |
| 2024 | $51.96M | +71.4% |
| 2023 | $30.31M | +11.9% |
| 2022 | $27.08M | +14.1% |
| 2021 | $23.73M | +287.1% |
| 2020 | $6.13M | -24.6% |
| 2019 | $8.13M | +19.2% |
| 2018 | $6.82M | +237.1% |
| 2017 | $2.02M | -91.9% |
| 2016 | $25.02M | - |